INVASCENT
InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.
INVASCENT
Industry:
Health Care Pharmaceutical
Status:
Active
Contact:
040 2354 1305
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Apache Euro
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Rittenhouse Ventures
Rittenhouse Ventures invests in small rounds of capital-efficient Early-Growth stage companies primarily in Healthcare and Pharma IT.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Accumax | InvAscent investment in Private Equity Round - Accumax | 5.2 B INR |
| 2022-04-25 | Malladi Drugs | InvAscent investment in Private Equity Round - Malladi Drugs | 2.5 B INR |
| 2021-02-02 | MediBuddy | InvAscent investment in Series B - MediBuddy | 40 M USD |
| 2020-06-16 | Murli Krishna Pharma | InvAscent investment in Private Equity Round - Murli Krishna Pharma | 700 M INR |
| 2020-06-08 | Sharp Sight | InvAscent investment in Private Equity Round - Sharp Sight | 700 M INR |
| 2019-01-01 | Intron Life Sciences | InvAscent investment in Private Equity Round - Intron Life Sciences | 10 M USD |
| 2018-10-31 | Strides Pharma Science | InvAscent investment in Post-IPO Equity - Strides Pharma Science | 20 M USD |
| 2017-03-15 | Oliva Clinic | InvAscent investment in Series A - Oliva Clinic | 832 K USD |
| 2016-12-01 | Stericon Pharma | InvAscent investment in Private Equity Round - Stericon Pharma | 500 M INR |
| 2016-01-08 | Sandor | InvAscent investment in Seed Round - Sandor | 8.98 M USD |